CLChengli Li

Chengli Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chengli Li has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Ming Liu

    Department of Interventional MRI, Shandong Medical Imaging Research Institute affiliated to Shandong University, Shandong Key Laboratory of Advanced Medical Imaging Technologies and Applications, Jinan, Shandong, People's Republic of China

    2 shared publications
  • Roberto Blanco Sequeiros

    Department of Radiology, Turku University Hospital, University of Turku, 20014 Turku, Finland

    2 shared publications
  • Bin Liu

    Department of Nuclear Medicine, Taian City Central Hospital, Shandong, People's Republic of China

    1 shared publication
  • Chao Liu

    Department of Nuclear Medicine, Taian City Central Hospital, Shandong, People's Republic of China

    1 shared publication
  • Dao-Ling Ren

    Department of Nuclear Medicine, Taian City Central Hospital, Shandong, People's Republic of China

    1 shared publication
  • Dong Chen

    University of Jinan-Shandong Academy of Medical Science

    1 shared publication

Latest Publications

  • Open Access

    Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer

    by Rong-Bin Lv, Qing-Gang Wang, Chao Liu, Fang Liu, Qing Zhao, Jian-Guo Han, Dao-Ling Ren, Bin Liu, Cheng-Li Li

    Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer Rong-Bin Lv,1,2 Qing-Gang Wang,2 Chao Liu,2 Fang Liu,2 Qing Zhao,3 Jian-Guo Han,2 Dao-Ling Ren,2 Bin Liu,2 Cheng-Li Li1 1Department of Interventional MRI, Shandong Medical Imaging Research Institute, Shandong University, Shandong, People’s Republic of China; 2Department of Nuclear Medicine, Taian City Central Hospital, Shandong, People’s Republic of China; 3Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China Aim: The aim of this study was to compare the efficacy and adverse effects of radioiodine (131I) therapy between two groups of patients with low-risk differentiated thyroid cancer (DTC) who received 30 mCi or 100 mCi radioiodine for ablation of the thyroid remnant after total thyroidectomy. Methods: The study cohort was 173 patients, 85 of whom were given 30 mCi of radioiodine and the others were given 100 mCi of radioiodine. Follow-up involved neck ultrasonography, measurement of serum levels of thyroglobulin and whole-body scans to evaluate the response of radioiodine treatment. All patients were assessed for adverse effects. Results: Of the 173 patients, 170 (98.3%) patients finally achieved successful ablation. The prevalence of successful ablation was 77.6% in the low-dose group versus 71.5% in the high-dose group after the first dose administration (P=0.36), 79% in the low-dose group versus 88% in the high-dose group after the second dose administration (P=0.416), and 97.6% in the low-dose group versus 98.9% in the high-dose group after the final ablation (P=0.54). We found no significant differences between the two groups. No patient had an adverse effect with a severity grade >2 and the prevalence of adverse effects in the high-dose group was higher than that in the low-dose group, especially for nausea, neck pain, and sore throat. Conclusion: These data suggest that a low dose of radioiodine is as effective as a high dose of radioiodine for ablation of the thyroid remnant after total thyroidectomy for low-risk DTC. Moreover, low-dose radioiodine therapy is associated with a lower prevalence of adverse events. Keywords: differentiated thyroid cancer, radioiodine, radiotherapy, thyroglobulin


  • MR-guided percutaneous biopsy of solitary pulmonary lesions using a 1.0-T open high-field MRI scanner with respiratory gating

    by Ming Liu, Jie Huang, Yujun Xu, Xiangmeng He, Lei Li, Yubo Lü, Qiang Liu, Roberto Blanco Sequeiros, Chengli Li


  • Diagnostic Accuracy of MRI-guided Percutaneous Transthoracic Needle Biopsy of Solitary Pulmonary Nodules

    by Shangang Liu, Chengli Li, Xuejuan Yu, Ming Liu, Tingyong Fan, Dong Chen, Pinliang Zhang, Ruimei Ren

    The purpose of our study was to evaluate the diagnostic accuracy of MRI-guided percutaneous transthoracic needle biopsy (PTNB) of solitary pulmonary nodules (SPNs). Retrospective review of 69 patients who underwent MR-guided PTNB of SPNs was performed. Each case was reviewed for complications. The final diagnosis was established by surgical pathology of the nodule or clinical and imaging follow-up. Pneumothorax rate and diagnostic accuracy were compared between two groups according to nodule diameter (≤2 vs. >2 cm) using χ 2 chest and Fisher’s exact test, respectively. The success rate of single puncture was 95.6 %. Twelve (17.4 %) patients had pneumothorax, with 1 (1.4 %) requiring chest tube insertion. Mild hemoptysis occurred in 7 (7.2 %) patients. All of the sample material was sufficient for histological diagnostic evaluation. Pathological analysis of biopsy specimens showed 46 malignant, 22 benign, and 1 nondiagnostic nodule. The final diagnoses were 49 malignant nodules and 20 benign nodules basing on postoperative histopathology and clinical follow-up data. One nondiagnostic sample was excluded from calculating diagnostic performance. A sensitivity, specificity, accuracy, positive predictive value, and negative predictive value in diagnosing SPNs were 95.8, 100, 97.0, 100, and 90.9 %, respectively. Pneumothorax rate, diagnostic sensitivity, and accuracy were not significantly different between the two groups (P > 0.05). MRI-guided PTNB is safe, feasible, and high accurate diagnostic technique for pathologic diagnosis of pulmonary nodules.


  • MRI-guided percutaneous coaxial cutting needle biopsy of small pulmonary nodules: feasibility

    by Ming Liu, Yubo Lv, Lebin Wu, Jiqing Song, Roberto Blanco Sequeiros, Chengli Li

    To prospectively evaluate the feasibility, safety and accuracy of magnetic resonance imaging (MRI)-guided percutaneous coaxial cutting needle biopsy of small (≤2.0 cm in diameter) pulmonary nodules. Ninety-six patients (56 men and 40 women) with 96 small lung nodules underwent MRI-guided percutaneous coaxial cutting needle biopsy. These lesions were divided into two groups according to maximum nodule diameters: 0.5–1.0 cm (n = 25) and 1.1–2.0 cm (n = 71). The diagnostic accuracy, sensitivity and specificity were calculated, and comparison of the two groups was performed using Fisher's exact test. All specimens obtained were sufficient for diagnosis. Histological examination of needle biopsy revealed 64 malignant, 30 benign and 2 indeterminate nodules. The final diagnoses from surgery or clinical follow-up were 67 malignant nodules and 29 benign nodules. The diagnostic performance of MRI-guided percutaneous coaxial cutting needle biopsy in diagnosing malignant tumours was as follows: accuracy, 97 %; sensitivity, 96 %; specificity, 100 %; positive predictive value, 100 %; and negative predictive value, 91 %. There was no significant difference between the two groups (P > 0.05, Fisher's exact test). No serious complications occurred. MRI-guided percutaneous coaxial cutting needle biopsy is a safe and accurate diagnostic technique in the evaluation of small lung nodules. • MRI-guided biopsy helps clinicians to assess patients with small lung nodules. • Differentiation of malignant and benign nodules is possible with 97 % accuracy. • MRI guidance enables accurate lung biopsy without ionising radiation. • No serious complications occurred in MRI-guided lung biopsy.